Use of a 6-miRNA panel to distinguish lymphoma from reactive lymphoid hyperplasia

Signal Transduct Target Ther. 2020 Jan 3;5(1):2. doi: 10.1038/s41392-019-0097-y.

Juanjuan Kang¹, Sisi Yu², Song Lu², Guohui Xu², Jiang Zhu^{3

4}, Na Yan⁴, Delun Luo^{3

4}, Kai Xu^{3

4}, Zhihui Zhang⁵, Jian Huang⁶

¹ Center for Informational Biology, University of Electronic Science and Technology of China, 611731, Chengdu, China.
² Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, 610041, Chengdu, China.
³ Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, 611137, Chengdu, China.
⁴ Research Center, Chengdu Nuoen Genomics, Ltd., 610041, Chengdu, China.
⁵ Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, 610041, Chengdu, China. 13881889739@139.com.
⁶ Center for Informational Biology, University of Electronic Science and Technology of China, 611731, Chengdu, China. hj@uestc.edu.cn.

No abstract available

Publication types